Clinical Effects of a Topically Applied Toll-like Receptor 9 Agonist in Active Moderate-to-Severe Ulcerative Colitis

por Atreya, Raja, Bloom, Stuart, Scaldaferri, Franco, Gerardi, Viviana, Admyre, Charlotte, Karlsson, Åsa, Knittel, Thomas, Kowalski, Jan, Lukas, Milan, Löfberg, Robert, Nancey, Stephane, Petryka, Robert, Rydzewska, Grazyna, Schnabel, Robert, Seidler, Ursula, Neurath, Markus F., Hawkey, Christopher
Publicado 2016

The TLR9 Agonist Cobitolimod Induces IL10-Producing Wound Healing Macrophages and Regulatory T Cells in Ulcerative Colitis

por Schmitt, Heike, Ulmschneider, Julia, Billmeier, Ulrike, Vieth, Michael, Scarozza, Patrizio, Sonnewald, Sophia, Reid, Stephen, Atreya, Imke, Rath, Timo, Zundler, Sebastian, Langheinrich, Melanie, Schüttler, Jürgen, Hartmann, Arndt, Winkler, Thomas, Admyre, Charlotte, Knittel, Thomas, Dieterich Johansson, Christine, Zargari, Arezou, Neurath, Markus F, Atreya, Raja
Publicado 2020